- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05477628
Nutrition Recommendation Intervention trialS in Children's Healthcare (NuRISH)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michelle Mitchell, BA
- Phone Number: 4165255417
- Email: michelle.mitchell@sickkids.ca
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy by parental report
- <32 weeks gestation
- 0-1 week of age
- First birth /first time parents
Exclusion Criteria:
- Children with a syndrome associated with obesity or developmental delay
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control Group
Participants who are randomized to the control group will receive usual care from their health care practitioners.
|
All children randomized to the control condition will receive age-appropriate nutritional recommendations as part of routine healthcare.
|
|
Experimental: Intervention Group
Participants who are randomized to Intervention Group will receive one of three possible "scenarios": 1) Childcare Navigator Support, 2) Breastfeeding support via Lactation Consultant, 3) both Childcare Navigator Support and Breastfeeding support via Lactation.
|
Participants will be contacted by the CN to assist with access to centre-based childcare after enrolment. The CN will: a) educate the family on the benefits of centre based childcare; b) facilitate placement of the child on waiting lists for funding and centre based childcare placement in their neighbourhood with the aim of having full-time centre based childcare start at 1 year of age; and c) work with the family to overcome barriers to childcare placement prior to and during childcare. It is expected that the child will be in full-time centre-based childcare for a minimum of 12 months. Control: All children randomized to the control condition will receive age-appropriate nutritional recommendations as part of routine healthcare according to the Rourke Baby Record.
Other Names:
Participants will be contacted by the LC on the same day as their first primary healthcare visit. They will also receive age-appropriate nutrition recommendations according to the Rourke Baby Record. The LC will be an International Board Certified Lactation Consultant (IBCLC) who will provide scheduled and on-call visits, along with phone calls, video conferencing, and text messaging as needed to support exclusive breastfeeding (using virtual care modalities as appropriate during COVID-19). The LC will contact the family once per week for the first 4 weeks to support breastfeeding technique and help with breastfeeding problems such as latching difficulties, painful nursing, and low milk production, monthly thereafter and provide on-call support as required to support exclusive breastfeeding through 6 months of age. Control: All children randomized to the control condition will receive age-appropriate nutritional recommendations as part of routine healthcare.
Other Names:
This intervention is a combination of the two interventions described above.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
zBMI
Time Frame: 2-year primary healthcare visit
|
The primary outcome measure will be age and sex standardized BMI z-score (zBMI), which will be measured at the 2-year primary healthcare visit.
zBMI is an important outcome that is predictive of adiposity in later childhood, adolescence and adulthood.
Data including birthweight and length, and repeated measures of weight and length will be used to calculate zBMI growth trajectories.
|
2-year primary healthcare visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
breastfeeding self-efficacy
Time Frame: 6 months
|
change in breastfeeding self-efficacy measured by lactation consultant logs
|
6 months
|
|
exclusive breastfeeding duration
Time Frame: 6 months
|
change in exclusive breastfeeding duration
|
6 months
|
|
Childcare attendance
Time Frame: 2 years of age
|
change in centre-based childcare attendance measured by attendance logs
|
2 years of age
|
|
cognitive development
Time Frame: 2 years of age
|
To capture child's development, the Ages and Stages Questionnaire will be administered.
The Ages and Stages Questionnaire identifies infants, toddlers and preschool aged children at risk of a developmental delay in five developmental domains: Communication, Gross Motor, Fine Motor, Problem Solving and Personal Social Behaviour.
Each domain consists of six questions about important age-specific developmental milestones.
If a child scores between 1 and 2 below the normative mean on any domain, rescreening is recommended.
When a child scores 1 below the normative mean on two or more domains, or 2 below the normative mean on at least one domain, a referral to a health care professional is recommended.
|
2 years of age
|
|
maternal mental health
Time Frame: 2 years of age
|
change in maternal mental health, measured by the Edinburgh Postnatal Depression Scale at 2 years of age.
The scale was developed for screening postpartum women in outpatient, home visiting settings, or at the 6 -8 week postpartum examination.
Consisting of 10 questions, each response is scored 0, 1, 2, or 3 according to increased severity of the symptom.
Items marked with an asterisk (*) are reverse scored (i.e., 3, 2, 1, and 0).
The total score is determined by adding together the scores for each of the 10 items.
A woman scoring 9 or more points or indicating any suicidal ideation - that is she scores 1 or higher on question #10 - should be referred immediately for follow-up.
Even if a woman scores less than 9, if the clinician feels the client is suffering from depression, an appropriate referral should be made.
|
2 years of age
|
|
mental health
Time Frame: 2 years of age
|
Child's mental health captured by the Strengths and Difficulties Questionnaire.
The questionnaire consists of 25 items subdivided into four difficulties scales, emotional symptoms, conduct problems, inattention-hyperactivity and peer problems, and a separate fifth strength scale, prosocial behavior.
All subscales have five questions.
Each item has to be scored on a 3-point scale with 0 = 'not true', 1 = 'somewhat true' and 2 = 'certainly true'.
A higher score indicates more emotional and behavioral problems.
|
2 years of age
|
|
blood pressure
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
non-HDL
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
LDL
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
triglyceride
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
HDL
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
TC
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
glucose
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
hsCRP
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
HbA1C
Time Frame: 2 years of age
|
change in cardiovascular risk factors for the child
|
2 years of age
|
|
Dietary Quality
Time Frame: 2 years of age
|
total caloric intake captured through the Automated Self-Administered 24-hour Dietary Assessment Tool of the child and mother at 2 years of age
|
2 years of age
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jonathon Maguire, MD,FRCPC,MSc, The Hospital for Sick Children
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3606
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
Steno Diabetes Center CopenhagenNot yet recruitingDiabetes | Diabetes Type 1 | Diabetes Type 2 | Digital Health | Diabetes Care | Remote Patient MonitoringDenmark
-
DiappyMedSanoiaRecruitingDiabetes Type 1 | Pancreatogenous Diabetes | Diabetes Type 2 on InsulinFrance
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
Clinical Trials on Control Group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Chengdu Sport UniversityNot yet recruiting
-
Hanlim Pharm. Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruitingAdolescent Idiopathic ScoliosisChina
-
International University of La RiojaCompletedPsychosis | Therapy | PsychologicalSpain
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
Physicians Committee for Responsible MedicineMetropolitan Police Department of Washington, D.C.SuspendedDiabetes Mellitus, Type 2 | Overweight | Blood PressureUnited States
-
University of MaltaNot yet recruiting